Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C15H18N2O |
Molecular Weight | 242.3162 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
C\C=C1/[C@@H]2CC3=C(C=CC(=O)N3)[C@@]1(N)CC(C)=C2
InChI
InChIKey=ZRJBHWIHUMBLCN-YQEJDHNASA-N
InChI=1S/C15H18N2O/c1-3-11-10-6-9(2)8-15(11,16)12-4-5-14(18)17-13(12)7-10/h3-6,10H,7-8,16H2,1-2H3,(H,17,18)/b11-3+/t10-,15+/m0/s1
Molecular Formula | C15H18N2O |
Molecular Weight | 242.3162 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 1 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:28:04 UTC 2023
by
admin
on
Fri Dec 15 16:28:04 UTC 2023
|
Record UNII |
0111871I23
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
744420
Created by
admin on Fri Dec 15 16:28:04 UTC 2023 , Edited by admin on Fri Dec 15 16:28:04 UTC 2023
|
||
|
DSLD |
708 (Number of products:164)
Created by
admin on Fri Dec 15 16:28:04 UTC 2023 , Edited by admin on Fri Dec 15 16:28:04 UTC 2023
|
||
|
NCI_THESAURUS |
C66880
Created by
admin on Fri Dec 15 16:28:04 UTC 2023 , Edited by admin on Fri Dec 15 16:28:04 UTC 2023
|
||
|
DSLD |
3336 (Number of products:266)
Created by
admin on Fri Dec 15 16:28:04 UTC 2023 , Edited by admin on Fri Dec 15 16:28:04 UTC 2023
|
||
|
FDA ORPHAN DRUG |
559916
Created by
admin on Fri Dec 15 16:28:04 UTC 2023 , Edited by admin on Fri Dec 15 16:28:04 UTC 2023
|
||
|
FDA ORPHAN DRUG |
885322
Created by
admin on Fri Dec 15 16:28:04 UTC 2023 , Edited by admin on Fri Dec 15 16:28:04 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
178022
Created by
admin on Fri Dec 15 16:28:04 UTC 2023 , Edited by admin on Fri Dec 15 16:28:04 UTC 2023
|
PRIMARY | |||
|
HUPERZINE A
Created by
admin on Fri Dec 15 16:28:04 UTC 2023 , Edited by admin on Fri Dec 15 16:28:04 UTC 2023
|
PRIMARY | |||
|
DB04864
Created by
admin on Fri Dec 15 16:28:04 UTC 2023 , Edited by admin on Fri Dec 15 16:28:04 UTC 2023
|
PRIMARY | |||
|
SUB127430
Created by
admin on Fri Dec 15 16:28:04 UTC 2023 , Edited by admin on Fri Dec 15 16:28:04 UTC 2023
|
PRIMARY | |||
|
102518-79-6
Created by
admin on Fri Dec 15 16:28:04 UTC 2023 , Edited by admin on Fri Dec 15 16:28:04 UTC 2023
|
PRIMARY | |||
|
100000153436
Created by
admin on Fri Dec 15 16:28:04 UTC 2023 , Edited by admin on Fri Dec 15 16:28:04 UTC 2023
|
PRIMARY | |||
|
m6064
Created by
admin on Fri Dec 15 16:28:04 UTC 2023 , Edited by admin on Fri Dec 15 16:28:04 UTC 2023
|
PRIMARY | Merck Index | ||
|
854026
Created by
admin on Fri Dec 15 16:28:04 UTC 2023 , Edited by admin on Fri Dec 15 16:28:04 UTC 2023
|
PRIMARY | |||
|
DTXSID8046038
Created by
admin on Fri Dec 15 16:28:04 UTC 2023 , Edited by admin on Fri Dec 15 16:28:04 UTC 2023
|
PRIMARY | |||
|
2267703
Created by
admin on Fri Dec 15 16:28:04 UTC 2023 , Edited by admin on Fri Dec 15 16:28:04 UTC 2023
|
PRIMARY | |||
|
0111871I23
Created by
admin on Fri Dec 15 16:28:04 UTC 2023 , Edited by admin on Fri Dec 15 16:28:04 UTC 2023
|
PRIMARY | |||
|
0111871I23
Created by
admin on Fri Dec 15 16:28:04 UTC 2023 , Edited by admin on Fri Dec 15 16:28:04 UTC 2023
|
PRIMARY | |||
|
SUB33678
Created by
admin on Fri Dec 15 16:28:04 UTC 2023 , Edited by admin on Fri Dec 15 16:28:04 UTC 2023
|
ALTERNATIVE | |||
|
C97271
Created by
admin on Fri Dec 15 16:28:04 UTC 2023 , Edited by admin on Fri Dec 15 16:28:04 UTC 2023
|
PRIMARY | |||
|
C050426
Created by
admin on Fri Dec 15 16:28:04 UTC 2023 , Edited by admin on Fri Dec 15 16:28:04 UTC 2023
|
PRIMARY | |||
|
78330
Created by
admin on Fri Dec 15 16:28:04 UTC 2023 , Edited by admin on Fri Dec 15 16:28:04 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SOLVATE->ANHYDROUS |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
TARGET -> INHIBITOR |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PRODRUG -> METABOLITE ACTIVE |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|